This study evaluates the safety, effectiveness, and maintenance of effect of a novel topical silver particle solution (Sienna 755.1100, 810.1100, or 1064.1100) used in conjunction with a laser for the treatment of Acne Vulgaris.
Study Type
OBSERVATIONAL
Enrollment
76
Unnamed facility
Scottsdale, Arizona, United States
Unnamed facility
Santa Monica, California, United States
Unnamed facility
Coral Gables, Florida, United States
Change in Total lesion count by blinded investigator
Maintenance of effect by comparing lesion counts conducted at the exit visit of the predecessor study (ie, 12 weeks post-final treatment) and visit 2 of this study (ie, 18 weeks post-final treatment).
Time frame: 18 weeks post final treatment
Change in Total lesion count by blinded investigator
Maintenance of effect by comparing lesion counts conducted at the exit visit of the predecessor study (ie, 12 weeks post-final treatment) and visit 3 of this study (ie, 24 weeks post-final treatment).
Time frame: 24 weeks post final treatment
Safety as assessed by number of adverse events
Adverse events will be monitored throughout the study
Time frame: up to 24 weeks post final treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Miami, Florida, United States
Unnamed facility
Hunt Valley, Maryland, United States
Unnamed facility
Beverly, Massachusetts, United States
Unnamed facility
St Louis, Missouri, United States
Unnamed facility
Hackensack, New Jersey, United States
Unnamed facility
Charlotte, North Carolina, United States
Unnamed facility
Yardley, Pennsylvania, United States
...and 6 more locations